The Week in Review: June 29 – July 6, 2018

Friday, July 6, 2018 News Recap: Updated and New Materials from HepCBC. Recently HepCBC updated some of its pamphlets and added some new materials, all of which can be easily downloaded from our site and which you can print out or order from us. Got Hep C from transfusion, blood product, or transplant between 1986 and 1990? Haven't applied for compensation yet? This news is for you. Good luck!  https://toronto.ctvnews.ca/video?clipId=1324976 What...

The Week in Review: June 22 – June 29, 2018

Friday, June 29, 2018 News Recap: Canada: Boomer Moms At High Risk For Hep C, Says Doctor. A quarter million Canadians are believed to have the hepatitis C virus at this moment, and many have no idea. Dr. Rod Russell says it’s really baby boomers at the highest risk, and to be specific, it’s our mothers, the women who gave birth before 1992, especially if they had blood transfusions during pregnancy. Their children are also at risk because if the mo...

The Week in Review: June 15 – June 22, 2018

Friday, June 22, 2018 News Recap: Canada: All Kids Should Have a Hepatitis B Shot. Clinicians and researchers attending an international conference say all Canadian children should be vaccinated against hepatitis B starting at birth to prevent the development of potentially deadly liver disease later in life, a policy recommended by the World Health Organization. Currently, most provinces and territories immunize children against the liver-destroyin...

The Week in Review: June 8 – June 15, 2018

Friday, June 15, 2018 News Recap: Canada: Canada is facing a tsunami of liver disease and cancer: U of T expert – The Conversation with U of T's Dr. Morris Sherman. Deaths from liver cancer in Canada have doubled over the past 25 years. And to make matters worse, there’s an epidemic of liver cancer on the horizon if action isn’t taken soon. While less people are dying from most major cancers – such as breast cancer and lung cancer – liver cancer (...

Weekly Bull May 2018

The Week in Review: May 25, 2018 – June 1, 2018 Friday, June-1-18 News Recap US HCV Guidelines updated with recommendations for pregnant women, prisoners and MSM, DAAs and liver cancer, durability of HBV vaccine, CRV431 (cyclophilin inhibitors) and liver cancer, HCV and gut dysbiosis..... Read more…http://hepcbc.ca/2018/06/01/the-week-in-review-may-25-june-1-2018/ The Week in Review: May 18, 2018 – May 25, 2018 Friday, May-25-18 News Recap ...

The Week in Review: June 1 – June 8, 2018

Friday, June 8, 2018 News Recap: Canada: New guidelines recommend hepatitis C screening be done for those born between 1945 and 1975. The Canadian Association for the Study of the Liver (CASL), a national group of health-care providers and researchers, published its guidelines on testing and treating hepatitis C in Monday's edition of the CMAJ. Canadians born between 1945 and 1975 – essentially the baby-boom generation – should be tested for the pot...

The Week in Review: May 25 – June 1, 2018

Friday, June 1, 2018 News Recap: HCV: Large Study Confirms DAAs Protect Against HCC When Sustained Viral Response Achieved. Patients with hepatitis C virus who are successfully treated with direct-acting antiviral agents experience a dramatic reduction in their risk for liver cancer, new data show. However, the decrease is much lower for those diagnosed with cirrhosis before starting a DAA. HCV Guidance Updated for Screening and Treating Key Popu...

The Week in Review: May 18 – May 25, 2018

Friday, May 25, 2018 News Recap: In Brief: Liver Stiffness Measurement as a Potential Screening Tool for Liver-Related Events in HCV. The rate of advanced liver fibrosis in community as opposed to urban settings appears to be significant (16.5%) and often underdiagnosed; therefore, liver stiffness measurement is a feasible community screening tool that can be used to predict liver-related events, according to a study published in the Journal of He...

The Week in Review: May 11 – May 18, 2018

Friday, May 18, 2018 News Recap: Canada: Promoting Drug Pricing Policy Resources for Patient Groups. Patient groups in Canada shared in a recent survey that they struggle to understand the complexities of drug pricing policy in Canada and that they would like more information. In response, the Drug Pricing Policy Summit Working Groups have put together two web pages that outline various resources and learning opportunities to help patient groups lea...

The Week in Review: April 28 – May 11, 2018

Friday, May 11, 2018 News Recap: HBV: CADTH recommends that tenofovir alafenamide (TAF) be reimbursed for the treatment of chronic hepatitis B. The CADTH Canadian Drug Expert Committee (CDEC) recommends that tenofovir alafenamide (TAF) be reimbursed for the treatment of chronic hepatitis B in adults with compensated liver disease, if the following condition is met: CONDITION: The drug plan cost of TAF should not exceed that of the lowest-cost prepar...